Arbutus Biopharma Corporation - stock earnings
ABUS Upcoming estimated earnings
Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
---|---|---|---|---|
May 2, 2024 BeforeMarket | -0.10 / -0.11 | - | 1.5 million / 2.2 million | - |
Aug. 1, 2024 BeforeMarket | - / - | 1.5 million | - / 2.0 million | 2.3 million |
ABUS Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2024Q1 | -17.9 million USD | 1.5 million USD |
2023Q4 | -19.3 million USD | 2.1 million USD |
2023Q3 | -20.1 million USD | 4.7 million USD |
2023Q2 | -17.1 million USD | 4.7 million USD |
2023Q1 | -15.5 million USD | 6.7 million USD |
2022Q4 | -22.9 million USD | 6.2 million USD |
2022Q3 | -17.3 million USD | 6.0 million USD |
2022Q2 | -14.3 million USD | 14.2 million USD |
2022Q1 | -15.8 million USD | 12.6 million USD |
2021Q4 | -21.3 million USD | 3.2 million USD |
2021Q3 | -19.2 million USD | 3.3 million USD |
2021Q2 | -19.4 million USD | 2.3 million USD |
2021Q1 | -16.4 million USD | 2.1 million USD |
2020Q4 | -17.0 million USD | 2.4 million USD |
2020Q3 | -18.8 million USD | 1.5 million USD |
2020Q2 | -14.1 million USD | 1.5 million USD |
2020Q1 | -13.9 million USD | 1.5 million USD |
2019Q4 | -24.7 million USD | 1.6 million USD |
2019Q3 | -82.5 million USD | 3.1 million USD |
2019Q2 | -23.3 million USD | 653000 USD |
2019Q1 | -23.3 million USD | 679000 USD |
2018Q4 | -18.2 million USD | 1.7 million USD |
2018Q3 | -24.5 million USD | 1.6 million USD |
2018Q2 | 3.1 million USD | 1.2 million USD |
2018Q1 | -17.4 million USD | 1.4 million USD |
2017Q4 | -35.9 million USD | 2.5 million USD |
2017Q3 | -11.6 million USD | 6.9 million USD |
2017Q2 | -18.3 million USD | 1.0 million USD |
2017Q1 | -18.6 million USD | 235000 USD |
2016Q4 | -218.7 million USD | -195000 USD |
2016Q3 | -19.6 million USD | 774000 USD |
2016Q2 | -130.0 million USD | 309000 USD |
2016Q1 | -15.9 million USD | 603000 USD |
2015Q4 | -5.3 million USD | 12.7 million USD |
2015Q3 | -29.0 million USD | 4.1 million USD |
2015Q2 | -14.9 million USD | 3.4 million USD |
2015Q1 | -12.0 million USD | 4.7 million USD |
2014Q4 | -6.2 million USD | 4.4 million USD |
2014Q3 | -8.6 million USD | 4.4 million USD |
2014Q2 | -6.1 million USD | 1.8 million USD |
2014Q1 | -18.0 million USD | 4.4 million USD |
2013Q4 | -2.6 million USD | 7.5 million USD |
2013Q3 | -5.9 million USD | 3.0 million USD |
2013Q2 | -3.0 million USD | 2.8 million USD |
2013Q1 | -2.6 million USD | 2.2 million USD |
2012Q4 | 38.6 million USD | 3.8 million USD |
2012Q3 | -3.5 million USD | 3.1 million USD |
2012Q2 | -1.9 million USD | 3.6 million USD |
2012Q1 | -3.2 million USD | 3.6 million USD |
2011Q4 | -1.9 million USD | 3.9 million USD |
2011Q3 | -1.4 million USD | 4.0 million USD |
2011Q2 | -3.6 million USD | 4.6 million USD |
2011Q1 | -1.5 million USD | 6.7 million USD |
2010Q4 | -1.5 million USD | 6.7 million USD |
2010Q3 | -2.6 million USD | 10.1 million USD |
2010Q2 | -4.0 million USD | 2.2 million USD |
2010Q1 | -4.3 million USD | 2.4 million USD |
2009Q4 | -2.6 million USD | 4.5 million USD |
2009Q3 | -2.6 million USD | 3.1 million USD |
2009Q2 | -1.9 million USD | 3.3 million USD |
2009Q1 | -1.6 million USD | 2.3 million USD |
2008Q4 | -1.0 million USD | 1.5 million USD |
2008Q3 | -5.7 million USD | 4.0 million USD |
2008Q2 | -4.8 million USD | 2.5 million USD |
2008Q1 | -421548 USD | 1.9 million USD |
2007Q4 | 357853 USD | 4.3 million USD |
2007Q3 | 1.5 million USD | 5.8 million USD |
2007Q2 | -4.8 million USD | 2.8 million USD |
2007Q1 | 615491 USD | 2.5 million USD |
2006Q4 | 146667 USD | 2.4 million USD |
2006Q3 | 3.2 million USD | 6.3 million USD |
2006Q2 | 19.0 million USD | 5.4 million USD |
2006Q1 | ? USD | 9415 USD |
2005Q4 | ? USD | 13.2 million USD |
2005Q2 | -6.6 million USD | 12.6 million USD |
2005Q1 | 6.7 million USD | 12.8 million USD |
2004Q4 | ? USD | 3.6 million USD |
2004Q3 | ? USD | 2.6 million USD |
2004Q2 | ? USD | 2.5 million USD |
2004Q1 | ? USD | 2.8 million USD |
2003Q4 | ? USD | 185042 USD |
2003Q3 | ? USD | 609107 USD |
2003Q2 | ? USD | 88351 USD |
2003Q1 | ? USD | 1.6 million USD |
2002Q4 | ? USD | 578622 USD |
2002Q3 | ? USD | 271598 USD |
2002Q2 | ? USD | 3.0 million USD |
2002Q1 | ? USD | 1.3 million USD |
2001Q4 | ? USD | 1.1 million USD |
2001Q3 | ? USD | 1.1 million USD |
2001Q2 | ? USD | 754953 USD |
2001Q1 | ? USD | 166318 USD |
2000Q4 | ? USD | 48260 USD |
2000Q2 | ? USD | 48635 USD |
2000Q1 | ? USD | 49686 USD |
ABUS Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -72.8 million USD | 18.1 million USD |
2022 | -69.5 million USD | 39.0 million USD |
2021 | -77.4 million USD | 11.0 million USD |
2020 | -65.2 million USD | 6.9 million USD |
2019 | -153.7 million USD | 6.0 million USD |
2018 | -57.1 million USD | 5.9 million USD |
2017 | -84.4 million USD | 10.7 million USD |
2016 | -384.1 million USD | 1.5 million USD |
2015 | -61.1 million USD | 24.9 million USD |
2014 | -38.8 million USD | 15.0 million USD |
2013 | -14.1 million USD | 15.5 million USD |
2012 | 29.9 million USD | 14.2 million USD |
2011 | -9.7 million USD | 16.3 million USD |
2010 | -12.4 million USD | 21.4 million USD |
2009 | -9.3 million USD | 13.8 million USD |
2008 | -11.7 million USD | 9.6 million USD |
2007 | -2.6 million USD | 15.9 million USD |
2006 | 18.1 million USD | 13.6 million USD |
2005 | -8.1 million USD | 13.3 million USD |
2004 | -28.0 million USD | 12.2 million USD |
2003 | -34.1 million USD | 2.7 million USD |
2002 | -26.8 million USD | 5.1 million USD |
2001 | -14.0 million USD | 3.5 million USD |
2000 | -9.2 million USD | 1.8 million USD |
1999 | -8.2 million USD | 1.1 million USD |
1998 | -8.8 million USD | 1.2 million USD |
ABUS
Price: $2.82
52 week price:
Earnings Per Share: -0.44 USD
P/E Ratio: -5.13
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 545700
Ebitda: -10.9 millionMarket Capitalization: 488.3 million